logo

Biogen Inc. (BIIB)



Trade BIIB now with
  Date
  Headline
11/29/2022 7:54:39 PM Eisai Presents Full Results Of Lecanemab Phase 3 Confirmatory Clarity Ad Study For Early Alzheimer's Disease
11/14/2022 10:30:29 AM Uptrend Continues For Biogen Shares
11/10/2022 8:22:45 AM Biogen Names Christopher Viehbacher President And CEO, Effective Nov 14
10/25/2022 7:43:47 AM Biogen Raises 2022 Guidance
10/25/2022 7:07:26 AM Biogen Q3 GAAP EPS $7.84; Non-GAAP EPS $4.77
10/17/2022 7:34:17 AM Biogen Announces FDA's 3-Month Extension Of Review Period For Tofersen NDA
9/30/2022 7:08:40 AM Biogen: European Medicines Agency Accepts Marketing Authorization Application For BIIB800
7/20/2022 8:06:40 AM Biogen Inc. (BIIB) Has Raised Its FY22 Revenue Estimate To $9.9 - $10.1 Bln From $9.7 - $10.0 Bln
7/20/2022 8:06:00 AM Biogen Inc. (BIIB) Has Raised Its FY22 EPS Estimate To 15.25 - 16.75 From 14.25 - 16.00